First-line chemotherapy for ovarian cancer – the controversy continues

Abstract

British Journal of Cancer (2002) 87, 813–814. doi:10.1038/sj.bjc.6600568 www.bjcancer.co

    Similar works

    Available Versions

    Last time updated on 05/06/2019